Regencell Bioscience Holdings Limited, a herbal medicine biotech firm, has experienced an astonishing 46,000% surge in its stock value in 2025, despite generating no revenue since its inception. This Hong Kong-based company, specializing in traditional Chinese medicine for neurological conditions, saw its market capitalization soar to $30 billion.
Related Posts
SC sets timeline for state governors to decide on bills sent to them
In an unprecedented move, the Supreme Court has deemed 10 Tamil Nadu bills, long delayed by the governor, as assented. The court criticized the governor’s […]
Dense fog envelops Delhi as IMD issues yellow alert; flight ops unaffected
A thin layer of fog covered parts of Delhi as the temperature fell to 7°C. Flight operations remain unaffected despite low visibility. The IMD issued […]
Close aide of Hafiz Saeed gunned down: LeT terrorist Abu Qatal killed in Pakistan
A top Lashkar-e-Taiba terrorist, Abu Qatal, known for his involvement in numerous attacks in Jammu and Kashmir, was shot dead by unidentified assailants in Pakistan’s […]